Â Â Â Â Â Â Â Â Â Â Â Â Â
The Laboratory of Excellence (LabEx) DEVweCAN invites applications for Junior group leader position in immunology in Research Cancer Institutions of Lyon
The LabEx DEVweCAN is looking for an outstanding junior scientist to establish his/her own innovative research program in the field of immunology in cancer linked to the LabEx DEVweCAN program (http://devwecan.universite-lyon.fr/).
The LabEx DEVweCAN is an academic research network financed by the â€śInvestissement dâ€™Avenirâ€ť Program (French National Research Agency). Its main mission is to strengthen the visibility of cancer research and training in Lyon, France. The LabEx DEVweCAN is built on the best research structures in Lyon, recognized by the French Authorities.
Based on the association of 11 research labs involved in development and oncology, the LabEx DEVweCAN project aims to develop innovative cancer research programs focused on embryonic mechanisms reactivated during tumor progression, cell death, stemness, cell migration, cell proliferation, epithelial-mesenchymal transition, metastasis, virus-induced cancer but also on cancer - immune system interface.
Currently three labs investigate the field of cancer and immunology. One investigates innate immune response after viral infection and its consequences on cell transformation. Another lab studies the mechanisms involved in immune surveillance and immune subversion by cancer cells while the last one is focused on the regulation of the immune response by the Transforming Growth Factor beta. All these labs belong to the Immunology Virology and Inflammation department composed of 9 labs within the Cancer Research Centre of Lyon (CRCL) including more than 450 people.
The present call aims to strengthen the Cancer Immunology field in Lyon, and face the current revolution of immunotherapy.
The close proximity between clinicians from anti-Cancer Hospitals, translational research groups and basic researchers offers a highly stimulating and collaborative research environment.
Any field linking cancer and the immune system will be eligible.
The appointment, which is available from January 2017 at the latest, is initially for 3 years meanwhile the post-holder should get a permanent position at the University of Lyon or French Research Institutions such as INSERM or CNRS. The successful candidates will receive a startup package, appropriate laboratory space and access to state-of-the art core facilities.
Applicants must hold a PhD or a M.D degree, international academic experience in immunology and should show an excellent track record of high quality scientific productivity, providing evidence of excellence in immunology research. Experience with group supervision and management, including success in obtaining extramural research fundings and supervising other scientists and PhD students will be considered an asset, but is not mandatory.
Applications, including a CV, a list of publications, a summary of scientific achievements (2 pages max.) an outline of the proposed scientific project (5 pages max.) and contact information of three referees should be sent to Emilie Dufour (email@example.com) before June 8th, 2016. Selected candidates will be invited for a skype interview in early July 2016 and then in Lyon by the end of August 2016.